Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na<sub>V</sub>1.5, K<sub>V</sub>1.5, and K<sub>2</sub>P channels for atrial fibrillation.
Ontology highlight
ABSTRACT: Atrial fibrillation (AF) involves electrical remodeling of the atria, with ion channels such as NaV1.5, KV1.5, and TASK-1 playing crucial roles. This study investigates acetamide-based compounds designed as multi-target inhibitors of these ion channels to address AF. Compound 6f emerged as the most potent in the series, demonstrating a strong inhibition of TASK-1 (IC50 ∼ 0.3 μM), a moderate inhibition of NaV1.5 (IC50 ∼ 21.2 μM) and a subtle inhibition of KV1.5 (IC50 ∼ 81.5 μM), alongside unexpected activation of TASK-4 (∼ 40% at 100 μM). Functional assays on human atrial cardiomyocytes from sinus rhythm (SR) and patients with AF revealed that 6f reduced action potential amplitude in SR (indicating NaV1.
SUBMITTER: Camargo-Ayala L
PROVIDER: S-EPMC12131194 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA